SPY423.34-0.97 -0.23%
DIA342.67-2.45 -0.71%
IXIC14,131.26+61.84 0.44%

Syndax Pharmaceuticals Q1 EPS $(0.54) Beats $(0.65) Estimate, Sales $379.00K Beat $220.00K Estimate

Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.65) by 16.92 percent. This is a 3.57 percent increase over losses of $(0.56) per share

05/11/2021 16:24
Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.65) by 16.92 percent. This is a 3.57 percent increase over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $379.00 thousand which beat the analyst consensus estimate of $220.00 thousand by 72.27 percent. This is the same as the same period last year.